Siyuan Ding’s Quest for Immunogenicity and Protective Efficacy of Rotavirus-ETEC Dual Vaccines

Siyuan Ding, PhD is an Assistant Professor of Molecular Microbiology at Washington University in St. Louis. He was awarded a 2023 Michelson Prize: Next Generation Grant for his proposal, “Immunogenicity and protective efficacy of rotavirus-ETEC dual vaccines.”

Dr. Ding's work seeks to develop a combined vaccine for rotavirus and enterotoxigenic Escherichia coli (ETEC), the leading viral and bacterial agents of diarrhea in infants.

With infectious diarrhea a leading cause of death among children, killing more each day than AIDS, malaria, and measles combined, his research could have a profound impact on child mortality.

Previous
Previous

Dennis Schaefer-Babajew Explores the Issue of Antibody Feedback Regulation on Adaptive Immune Responses

Next
Next

Claire Otero’s Path to Congenital Cytomegalovirus Vaccine Efficacy